Showing 12,701 - 12,720 results of 38,805 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 0.79s Refine Results
  1. 12701

    Table_1_Distribution patterns of fern species richness along elevations the Tibetan Plateau in China: regional differences and effects of climate change variables.docx by Muhammad Umair (4062583)

    Published 2023
    “…Here, we explore richness patterns of fern species in Xizang on the southern and western Tibetan Plateau along an elevational gradient (100–5300 m a.s.l.) and evaluate climatic factors causing the spatial decrease and increase of fern species richness. …”
  2. 12702

    Inter and intra-individual variation in γ-globin expression in baso-Es produced in the presence or absence of AFT024. by Amanda J. Grieco (751211)

    Published 2015
    “…Percent γ-globin was calculated as ((100*(Gγ + Aγ)/(Gγ + Aγ + β)). Error bars represent standard deviation in γ-globin levels over independent biological replicates. …”
  3. 12703

    DataSheet_1_Distribution patterns of fern species richness along elevations the Tibetan Plateau in China: regional differences and effects of climate change variables.docx by Muhammad Umair (4062583)

    Published 2023
    “…Here, we explore richness patterns of fern species in Xizang on the southern and western Tibetan Plateau along an elevational gradient (100–5300 m a.s.l.) and evaluate climatic factors causing the spatial decrease and increase of fern species richness. …”
  4. 12704

    Impact of law enforcement and increased traffic fines policy on road traffic fatality, injuries and offenses in Iran: Interrupted time series analysis by Milad Delavary Foroutaghe (6686225)

    Published 2020
    “…Second intervention was found to only affect the IRURTF with –26.75% (–37.49 to –16, 95% CI) which led to 0.222 casualties per 100 000 population. In addition, a reduction effect was observed on the incidence rate of illegal overtaking (IRIO) and the incidence rate of speeding (IRS) with –42.8% (–57.39 to –28.22, 95% CI) and –10.54% (–21.05 to –0.03, 95% CI which implied a decrease of 415.85 and 1003.8 in monthly traffic offenses per 100 000 vehicles), respectively.…”
  5. 12705
  6. 12706

    Mendelian randomization results of MR-Egger. by Haitao Li (305080)

    Published 2023
    “…The direction of the association of β-carotene with osteoporosis (OR = 0.844, p = 0.106, power = 87%) was consistent with that in the UKB dataset. A fixed-effects meta-analysis confirmed that β-carotene (OR = 0.862, p = 2.21 × 10<sup>−6</sup>) and γ-tocopherol (OR = 0.701, p = 2.31 × 10<sup>−2</sup>) could decrease the risk of osteoporosis. …”
  7. 12707

    Image 2_v1_Arthroscopy-assisted partial trapeziectomy combined with ligament reconstruction for thumb carpometacarpal joint osteoarthritis: A different technique.tif by Wan-Ling Zheng (13772251)

    Published 2022
    “…</p>Results<p>Ten patients were monitored at a mean follow-up of 6.8 years. The mean grip strength improved significantly from 16.64 to 22.57 kg after surgery. …”
  8. 12708

    Image 1_v1_Arthroscopy-assisted partial trapeziectomy combined with ligament reconstruction for thumb carpometacarpal joint osteoarthritis: A different technique.tif by Wan-Ling Zheng (13772251)

    Published 2022
    “…</p>Results<p>Ten patients were monitored at a mean follow-up of 6.8 years. The mean grip strength improved significantly from 16.64 to 22.57 kg after surgery. …”
  9. 12709

    Image 3_v1_Arthroscopy-assisted partial trapeziectomy combined with ligament reconstruction for thumb carpometacarpal joint osteoarthritis: A different technique.tif by Wan-Ling Zheng (13772251)

    Published 2022
    “…</p>Results<p>Ten patients were monitored at a mean follow-up of 6.8 years. The mean grip strength improved significantly from 16.64 to 22.57 kg after surgery. …”
  10. 12710
  11. 12711

    C-di-GMP binds MshE and PA14_29490 in the N-terminal T2SSE_N domain. by Kevin G. Roelofs (818861)

    Published 2015
    “…<p>Schematic of the truncations generated in (A) PA14_29490 and (E) MshE. C-di-GMP binding to <i>E</i>. …”
  12. 12712

    table3_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Although different antivirals are given for the clinical management of SARS-CoV-2 infection, their efficacy is still under evaluation. …”
  13. 12713

    table1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Although different antivirals are given for the clinical management of SARS-CoV-2 infection, their efficacy is still under evaluation. …”
  14. 12714

    image2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Although different antivirals are given for the clinical management of SARS-CoV-2 infection, their efficacy is still under evaluation. …”
  15. 12715

    table2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Although different antivirals are given for the clinical management of SARS-CoV-2 infection, their efficacy is still under evaluation. …”
  16. 12716

    image1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Although different antivirals are given for the clinical management of SARS-CoV-2 infection, their efficacy is still under evaluation. …”
  17. 12717

    table4_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Although different antivirals are given for the clinical management of SARS-CoV-2 infection, their efficacy is still under evaluation. …”
  18. 12718
  19. 12719
  20. 12720